Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • “MONOCAPRIN”—NATURAL EYE-DROP TO ERADICATE BLINDNESS IN INFANTS

KSCSTE Post Doctoral Fellowship 2020 | Applications Invited

AMNIOTIC BAND SYNDROME

“MONOCAPRIN”—NATURAL EYE-DROP TO ERADICATE BLINDNESS IN INFANTS
  • BiotechToday
  • World

“MONOCAPRIN”—NATURAL EYE-DROP TO ERADICATE BLINDNESS IN INFANTS

bioxone October 12, 2020October 11, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA

Researchers from Kingston University have found out an effective, natural eye drop for the infants who are subjected to a bacterial infection that causes blindness, without causing any kind of irritation. ‘Gonorrhoea’ which is a sexually transmitted disease (STD) caused by the bacteria “Neisseria gonorrhoeae” is resistant to the antibiotics used to nurse it. This contamination can be passed down from a pregnant mother to the baby and infect the eye if it not treated at the right time can ultimately lead to permanent blindness.

The research team from Kingston University has been surveying the prospective of the antimicrobial agent ‘monocaprin’ standing as an alternative measure to the treatment against gonorrhoea infections. The researchers trust that it has the probability to both eradicate the growing threat of the antibiotic resistance and also an easy-to-produce medication in the different parts of the world where accessing treatment is harder.

What is MONOCAPRIN?

It is a ‘monoglyceride’, which is indeed a modified fatty acid and the research team noted that it has the potentiality to kill ‘Neisseria gonorrhoeae’. The major journal Scientific Reports by Nature Research, the team has shown how it can be managed in an eye-drop without causing any irritation. The preparation was so far examined on bovine eyes obtained from abattoirs; the next step is to go for the human trials. Researchers are searching for natural agents which are high in monocaprin. 

Thus, monocaprin eye-drop stands as proof of how materials extracted from nature are useful to combat different critical conditions.

Also read: Coronavirus | Government to map out cold storage facilities for COVID-19 vaccine delivery

Citation: Churchward, C.O., et al. (2020) Monocaprin eye drop formulation to combat antibiotic-resistant gonococcal blindness.

Site: https://www.news-medical.net/news/20201009/Natural-eye-drop-could-help-fight-antibiotic-resistant-gonococcal-blindness-in-infants.aspx

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged antibiotic-resistant bacterial infection bovine eyes eye-drop Gonorrhoea Kingston university monocaprin monoglyceride Neisseria gonorrhoeae pregnant mother sexually transmitted disease

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Biotechnopedia
  • DNA-Tales

AMNIOTIC BAND SYNDROME

bioxone October 12, 2020

Pragya Raj, Amity University Kolkata  Amniotic Band Syndrome (ABS) is the congenital malformations related to the amniotic bands which entangle the fetal parts during the pregnancy term, results in a wide range of anatomical disturbances like constriction rings, bizarre multiple congenital anomalies. ABS occurs rarely but should be considered with a newborn with congenital anomalies. […]

AMNIOTIC BAND SYNDROME

Related Post

  • BiotechToday
  • World

Water in the liquid form found in an Ancient Meteorite

BioTech Today July 8, 2021July 7, 2021

Subhajit Nan, Amity University, Kolkata Scientists gain important insights into the formation of the solar system by studying meteorite fragments that hit the surface of the earth from space. Presently, in the latest study, they have found water in the liquid form, containing high levels of carbon dioxide, inside a meteorite from an asteroid that […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

FGFR1-targeted kinase inhibitors can now help in treating breast cancer

bioxone November 2, 2020November 2, 2020

Camelia Bhattacharyya, Amity University Kolkata Breast cancer, a term which scares most women, a type of cancer which changes the life of a patient even those who are survivors, is a much-studied and researched topic around the globe. The early symptoms might include the appearance of a lump at any portion of the breast, blood […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Eatable antibody factories to combat deadly gut infections!

bioxone October 31, 2020October 31, 2020

Jayateerth S. Bhavikatti, CSIR-National Chemical Laboratory, Pune. Clostridioides difficile (C. diff) is a causative agent for diarrhoea and colitis (colon inflammation) and its infection occurs usually during or soon after the administration of antibiotics. This happens as a result of wiping out the gut microbiome. In the US, nearly 30,000 people die annually from C. diff […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy